Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 63

1.

Neurobiology of Huntington's Disease: Applications to Drug Discovery.

Lo DC, Hughes RE, editors.

Boca Raton (FL): CRC Press/Taylor & Francis; 2011.

2.

High-Throughput and High-Content Screening for Huntington’s Disease Therapeutics.

Varma H, Lo DC, Stockwell BR.

In: Lo DC, Hughes RE, editors. Neurobiology of Huntington's Disease: Applications to Drug Discovery. Boca Raton (FL): CRC Press/Taylor & Francis; 2011. Chapter 5.

3.

Biomarkers to Enable the Development of Neuroprotective Therapies for Huntington’s Disease.

Hersch SM, Rosas HD.

In: Lo DC, Hughes RE, editors. Neurobiology of Huntington's Disease: Applications to Drug Discovery. Boca Raton (FL): CRC Press/Taylor & Francis; 2011. Chapter 11.

4.

Value of Invertebrate Genetics and Biology to Develop Neuroprotective and Preventive Medicine in Huntington’s Disease.

Neri C.

In: Lo DC, Hughes RE, editors. Neurobiology of Huntington's Disease: Applications to Drug Discovery. Boca Raton (FL): CRC Press/Taylor & Francis; 2011. Chapter 6.

5.

Protein Interactions and Target Discovery in Huntington’s Disease.

Miller JP, Hughes RE.

In: Lo DC, Hughes RE, editors. Neurobiology of Huntington's Disease: Applications to Drug Discovery. Boca Raton (FL): CRC Press/Taylor & Francis; 2011. Chapter 3.

6.

Genetic modifiers of Huntington's disease.

Gusella JF, MacDonald ME, Lee JM.

Mov Disord. 2014 Sep 15;29(11):1359-65. doi: 10.1002/mds.26001. Epub 2014 Aug 25. Review.

PMID:
25154728
7.

Update on Huntington's disease: advances in care and emerging therapeutic options.

Zielonka D, Mielcarek M, Landwehrmeyer GB.

Parkinsonism Relat Disord. 2015 Mar;21(3):169-78. doi: 10.1016/j.parkreldis.2014.12.013. Epub 2014 Dec 19. Review.

PMID:
25572500
8.

Screening of therapeutic strategies for Huntington's disease in YAC128 transgenic mice.

Gil-Mohapel JM.

CNS Neurosci Ther. 2012 Jan;18(1):77-86. doi: 10.1111/j.1755-5949.2011.00246.x. Review.

PMID:
21501423
9.

Huntington’s Disease: Clinical Experimental Therapeutics.

E. Ray D, Ira S.

In: Lo DC, Hughes RE, editors. Neurobiology of Huntington's Disease: Applications to Drug Discovery. Boca Raton (FL): CRC Press/Taylor & Francis; 2011. Chapter 12.

10.

Molecular Imaging Markers to Track Huntington's Disease Pathology.

Wilson H, De Micco R, Niccolini F, Politis M.

Front Neurol. 2017 Jan 30;8:11. doi: 10.3389/fneur.2017.00011. eCollection 2017. Review.

11.

Target Validation for Huntington’s Disease.

Kwak SP, Wang JKT, Howland DS.

In: Lo DC, Hughes RE, editors. Neurobiology of Huntington's Disease: Applications to Drug Discovery. Boca Raton (FL): CRC Press/Taylor & Francis; 2011. Chapter 4.

12.

Neurobiology of Huntington's Disease.

De Souza RA, Leavitt BR.

Curr Top Behav Neurosci. 2015;22:81-100. doi: 10.1007/7854_2014_353. Review.

PMID:
25205327
13.

Pharmaceutical Development for Huntington’s Disease.

Morse RJ, Leeds JM, Macdonald D, Park L, Toledo-Sherman L, Pacifici R.

In: Lo DC, Hughes RE, editors. Neurobiology of Huntington's Disease: Applications to Drug Discovery. Boca Raton (FL): CRC Press/Taylor & Francis; 2011. Chapter 8.

14.

Small molecule drug discovery for Huntington's Disease.

Fecke W, Gianfriddo M, Gaviraghi G, Terstappen GC, Heitz F.

Drug Discov Today. 2009 May;14(9-10):453-64. doi: 10.1016/j.drudis.2009.02.006. Epub 2009 Feb 25. Review.

PMID:
19429504
15.

Huntington’s Disease Pathogenesis: Mechanisms and Pathways.

La Spada AR, Weydt P, Pineda VV.

In: Lo DC, Hughes RE, editors. Neurobiology of Huntington's Disease: Applications to Drug Discovery. Boca Raton (FL): CRC Press/Taylor & Francis; 2011. Chapter 2.

16.

Emerging techniques for the discovery and validation of therapeutic targets for skeletal diseases.

Cho CH, Nuttall ME.

Expert Opin Ther Targets. 2002 Dec;6(6):679-89. Review.

PMID:
12472380
17.
18.

Preclinical and clinical investigations of mood stabilizers for Huntington's disease: what have we learned?

Scheuing L, Chiu CT, Liao HM, Linares GR, Chuang DM.

Int J Biol Sci. 2014 Sep 10;10(9):1024-38. doi: 10.7150/ijbs.9898. eCollection 2014. Review.

19.

Pharmaceutical, cellular and genetic therapies for Huntington's disease.

Handley OJ, Naji JJ, Dunnett SB, Rosser AE.

Clin Sci (Lond). 2006 Jan;110(1):73-88. Review.

PMID:
16336206
20.

Huntington's disease: from pathology and genetics to potential therapies.

Imarisio S, Carmichael J, Korolchuk V, Chen CW, Saiki S, Rose C, Krishna G, Davies JE, Ttofi E, Underwood BR, Rubinsztein DC.

Biochem J. 2008 Jun 1;412(2):191-209. doi: 10.1042/BJ20071619. Review.

PMID:
18466116

Supplemental Content

Support Center